Hemera Biosciences Competitors and Similar CompaniesClear all

Hemera Biosciences's competitors and similar companies include Ionis Pharmaceuticals, CRISPR Therapeutics and Omega Therapeutics.

	Hemera Biosciences Hemera Biosciences is a company that uses gene therapy as a one-time treatment in patients with age-related macular degeneration (AMD).	Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.	CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.	Omega Therapeutics Omega Therapeutics is an epigenomic medicine company.
Founding Date	Founding Date 2010	Founding Date 1989	Founding Date 2013	Founding Date 2017
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Waltham, US HQ	Locations Carlsbad, US HQ Vancouver, CA Stuttgart, DE Dublin, IE Dublin, IE Lisboa, PT London, GB see more	Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US	Locations Cambridge, US HQ
Employees	Employees 1	Employees 1,40231% increase	Employees 393	Employees 60
Valuation ($)	Valuation ($) N/A	Valuation ($) 6.3 b	Valuation ($) 4.2 b	Valuation ($) 68.4 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $943.7m (FY, 2025)	Revenue (est.) $3.5m (FY, 2025)	Revenue (est.) $3.1m (FY, 2023)
Net income	Net income N/A	Net income ($381.4m) (FY, 2025)	Net income ($581.6m) (FY, 2025)	Net income ($97.4m) (FY, 2023)
Funding
Total funding raised	Total funding raised $ 1.3m	Total funding raised N/A	Total funding raised $ 127m	Total funding raised $ 211m